OR WAIT null SECS
© 2021 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2021 MJH Life Sciences™ and Formulary Watch. All rights reserved.
October 21, 2021
Treating and managing patients with paroxysmal nocturnal hemoglobinuria is expensive and requires constant surveillance by the provider and health plan.
October 07, 2021
Investigators found only small differences in the change in LDL-C levels in the incentive groups versus the control group
Gavreto treats patients with advanced lung care and Arcalyst treats patients with recurrent pericarditis.
September 27, 2021
Repatha is now available for children 10 and older to lower low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolemia.
September 13, 2021
Jardiance demonstrated a 21% relative risk reduction for the composite primary endpoint of cardiovascular death or hospitalization for heart failure.
August 31, 2021
The full results from the Emperor-Preserved trial show Jardiance reduces the risk of hospital and death from heart failure.
August 24, 2021
Preliminary research shows Anplag could be repurposed as a heart failure treatment at a lower cost.
July 28, 2021
The findings were similar in people with or without diabetes.
July 27, 2021
Competition among branded products did not substantially curb annual spending increases.
July 26, 2021
Angiotensin receptor blockers may be less likely to cause side effects than ACE inhibitors.